November 1, 2016 10:23 AM EDT
News Briefing

Bon ap­petit: Cel­lec­tis CEO Chouli­ka hosts a gene-edit­ed feast; CRO Med­pace adding 650 staffers

Shehla Shakoor

Managing Director

Cel­lec­tis CEO An­dré Chouli­ka loves noth­ing bet­ter than cel­e­brat­ing the pi­o­neer­ing work he’s plan­ning to do with gene edit­ing and next-gen CAR-T. But he al­so …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times